Blockchain Technology in Healthcare Market Size, Share, Growth, and Industry Analysis, By Type (Public, Private), By Application (Supply chain management, Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, Other Applications), Regional Insights and Forecast to 2035

Blockchain Technology in Healthcare Market Overview

The global Blockchain Technology in Healthcare Market size estimated at USD 30596.76 million in 2026 and is projected to reach USD 423924.3 million by 2035, growing at a CAGR of 33.92% from 2026 to 2035.

The Blockchain Technology in Healthcare Market is advancing as healthcare organizations seek stronger data integrity, decentralized identity management, secure information exchange, pharmaceutical traceability, and automated administrative workflows. Private blockchain architectures are estimated to account for 68% of deployments because healthcare enterprises generally require permissioned participation, controlled data access, regulatory governance, and identifiable network members. Hospitals, pharmaceutical manufacturers, insurers, laboratories, research organizations, and technology providers are increasingly evaluating distributed ledgers as trust layers connecting systems without placing complete transaction authority under a single intermediary. Smart contracts are gaining importance for claims validation, provider credential verification, consent management, and supply-chain events, while off-chain storage models allow sensitive clinical information to remain protected while cryptographic proofs are maintained on distributed networks.

The United States represents approximately 38% of worldwide healthcare blockchain implementation activity, supported by extensive electronic health record adoption, complex insurance administration, digital-health investment, pharmaceutical supply-chain requirements, and strong demand for cybersecurity improvement. Healthcare organizations are increasingly examining blockchain for auditable patient consent, provider directories, clinical information exchange, medication verification, and transaction reconciliation. Permissioned networks are particularly suitable for regulated environments because access can be restricted to authenticated participants while maintaining immutable records of approved transactions. Integration with interoperability standards, cloud platforms, application programming interfaces, and decentralized identity technologies is also improving the ability of blockchain systems to operate alongside established healthcare IT infrastructure rather than requiring wholesale replacement of existing clinical platforms.

Key Findings

• Market Driver: Rising requirements for secure healthcare information exchange are accelerating adoption, with approximately 57% of enterprise blockchain initiatives focused on protecting clinical transactions, consent records, identities, or sensitive healthcare data.
• Major Market Restraint: Integration with established healthcare information systems remains a major barrier, with approximately 31% of prospective deployments encountering interoperability, legacy architecture, workflow redesign, or data-standardization constraints.
• Emerging Trends: Blockchain integration with artificial intelligence, Internet of Things platforms, and decentralized identity is expanding, with approximately 43% of emerging healthcare implementations evaluating at least one complementary digital technology.
• Regional Leadership: North America maintains a leading position with approximately 42% market share, supported by advanced digital-health infrastructure, extensive electronic records adoption, cybersecurity investment, and growing blockchain experimentation across healthcare ecosystems.
• Competitive Landscape: Strategic collaborations between technology companies, healthcare organizations, pharmaceutical participants, and specialized blockchain developers are increasing, with approximately 36% of commercial initiatives using partnership-led implementation models.
• Market Segmentation: Private blockchain leads product adoption with approximately 71% market share, while Supply chain management represents the largest application with approximately 35% as organizations prioritize pharmaceutical traceability and transaction verification.
• Recent Development: Cross-network healthcare data architectures are gaining momentum, with pilot systems demonstrating processing improvements above 25% through hybrid blockchain, off-chain storage, and interoperable data-exchange mechanisms.

Latest Trends

Permissioned blockchain combined with decentralized identity is becoming a major development direction because healthcare networks need to balance verifiable transactions with strict privacy controls. Blockchain integration with artificial intelligence, Internet of Things platforms, and decentralized identity is expanding, with approximately 43% of emerging healthcare implementations evaluating at least one Instead of storing complete medical records directly on-chain, organizations increasingly use blockchain to manage hashes, consent permissions, access histories, identities, and verification events while keeping clinical information in protected databases or distributed storage environments. This architecture can reduce unnecessary replication of sensitive information while maintaining a tamper-evident record of data activity. Decentralized identifiers and verifiable credentials are also gaining relevance for provider authentication, patient identity, professional licensing, and cross-organizational authorization, creating potential for more automated trust management across complex healthcare ecosystems.

Integration with smart contracts, artificial intelligence, connected medical devices, and interoperability platforms represents another important market trend. Approximately 47% of new solution designs include automated rules capable of triggering verification, approval, reconciliation, or notification processes after predefined conditions are satisfied. Smart contracts can support claims administration, pharmaceutical shipment tracking, research consent, provider verification, and supply-chain documentation without requiring every participating organization to maintain separate transaction records. Blockchain is also increasingly being positioned as an audit and provenance layer for artificial intelligence applications by recording data origin, model-access permissions, and selected processing events. Healthcare organizations are therefore shifting away from isolated blockchain experimentation toward hybrid digital architectures that connect distributed ledgers with existing cloud, API, electronic-record, analytics, and cybersecurity environments.

Blockchain Technology in Healthcare Market Dynamics

Driver

"Secure and trusted healthcare data exchange is accelerating blockchain adoption."

Rising requirements for secure healthcare information exchange are accelerating adoption, with approximately 57% of enterprise blockchain initiatives focused on protecting clinical transactions, consent records, identities, or sensitive healthcare data. Traditional healthcare systems frequently rely on centralized databases operated independently by hospitals, laboratories, insurers, pharmacies, and specialized providers, creating fragmented records and multiple trust boundaries. Blockchain can establish synchronized transaction histories across authorized participants while cryptographic controls help verify that recorded information has not been altered without detection. This capability is particularly valuable for patient-consent management, provider identity, laboratory results, clinical research records, and administrative transactions where participants require a shared record of when information was created, accessed, or approved.

Cybersecurity concerns further strengthen demand for distributed verification technologies as healthcare systems become increasingly interconnected. Approximately 53% of blockchain-oriented security projects focus on immutable audit trails, identity verification, access control, or integrity validation rather than direct storage of complete medical records. Permissioned distributed ledgers can record authentication events and cryptographic references without unnecessarily exposing protected clinical information to every network participant. When combined with encryption, tokenized permissions, and off-chain data storage, blockchain can provide an additional trust layer around existing healthcare applications. The technology does not eliminate cybersecurity risk, but it can reduce dependence on single-record authorities for selected workflows and provide investigators with a consistent history of authorized transactions, improving accountability across multi-organization healthcare networks.

Restraint

"Complex integration and regulatory requirements continue to restrict deployment."

Healthcare blockchain adoption is constrained by the complexity of integrating distributed networks with established electronic health records, billing platforms, laboratory systems, pharmacy applications, and insurance infrastructure. Approximately 34% of implementation difficulty can be associated with data normalization, interface development, legacy-system limitations, and differences in organizational workflows. Healthcare institutions rarely operate on identical technology stacks, making it difficult to create shared blockchain networks without substantial middleware and application programming interface development. Distributed ledger platforms must also coexist with existing clinical standards and identity systems rather than forcing providers to redesign every underlying application. Consequently, many implementations begin with limited transaction categories before expanding toward broader interoperability, which can slow commercialization and extend the period required to demonstrate measurable operational benefits.

Regulatory compliance represents another substantial restraint because distributed ledgers must support privacy, data correction, retention, access control, and jurisdiction-specific governance requirements. Approximately 28% of healthcare organizations evaluating blockchain identify regulatory interpretation and governance design as major considerations before production deployment. Blockchain's immutability provides strong auditability, but healthcare data regulations can require organizations to correct information, revoke permissions, limit access, or satisfy specific retention requirements. Architects therefore increasingly avoid storing sensitive patient information directly on-chain and instead record encrypted references, transaction proofs, permissions, or metadata. Establishing governance across several healthcare organizations can also be complicated because participants must agree on node operation, membership controls, dispute resolution, software updates, security responsibilities, and procedures for responding to compromised credentials.

Opportunity

"Interoperable digital ecosystems are creating new blockchain growth opportunities."

One of the strongest opportunities for Blockchain Technology in Healthcare lies in connecting fragmented healthcare data environments through permissioned, auditable exchange networks. Approximately 49% of prospective healthcare blockchain projects are being designed around cross-organizational workflows that require multiple parties to verify transactions without relying entirely on one centralized administrator. Clinical Data Exchange & Interoperability is particularly suited to this model because hospitals, laboratories, pharmacies, insurers, and research organizations often need to exchange information while maintaining independent systems. Blockchain can help synchronize consent status, patient identity, transaction history, and access permissions across participating institutions while off-chain repositories continue to store detailed medical records. This creates an opportunity to improve trust between systems without requiring every participant to use the same underlying clinical software.

Supply-chain applications also present major expansion potential as pharmaceutical and healthcare product networks become more complex. Approximately 35% of application demand is concentrated in Supply chain management, reflecting strong interest in product provenance, anti-counterfeit protection, shipment verification, and serialized transaction records. Blockchain can record manufacturing, custody transfer, storage, distribution, and dispensing events across authorized network participants, creating an auditable history for regulated products. Pharmaceutical companies and logistics partners can use shared ledgers to verify whether a product moved through approved channels and whether key transaction records match expected supply-chain events. As healthcare supply networks become increasingly global, blockchain-enabled traceability can strengthen compliance, reduce reconciliation time, and create a foundation for automated exception management using smart contracts.

Challenge

"Scalability and governance complexity remain persistent implementation challenges."

Healthcare blockchain networks can become difficult to scale when transaction volumes increase across large numbers of institutions, applications, and connected devices. Approximately 32% of enterprise implementation challenges are linked to throughput, latency, synchronization, data architecture, or network-management complexity. Public blockchain models can introduce performance and privacy limitations that are unsuitable for many clinical environments, while private systems require carefully designed governance to prevent excessive centralization. Healthcare transactions also differ significantly in size and urgency, ranging from identity checks and consent updates to complex claims and supply-chain events. Efficient architectures increasingly rely on off-chain processing, side networks, selective synchronization, and application-specific smart contracts to reduce congestion while preserving the integrity of key transaction records.

Governance presents an equally significant challenge because healthcare blockchain systems often involve institutions with different technical priorities, compliance obligations, risk tolerances, and operational processes. Approximately 30% of multi-party projects encounter delays associated with defining network membership, permissions, node responsibilities, dispute procedures, upgrade policies, and data-access rules. Healthcare organizations must agree on who can write transactions, who can validate them, how compromised credentials are handled, and how new participants join the network. These decisions can become more complex when insurers, hospitals, laboratories, pharmaceutical companies, regulators, and technology vendors participate simultaneously. Clear consortium governance and contractual frameworks are therefore essential for moving blockchain systems from limited pilots into stable production environments.

Blockchain Technology in Healthcare Market Segmentation 

By Types

Public: Public blockchain represents approximately 29% of the Blockchain Technology in Healthcare Market by type. This model allows wider network participation and can provide high transparency, distributed validation, and strong resistance to unilateral record manipulation. Public systems are generally more suitable for use cases where transaction proofs, verification events, or selected non-sensitive information can be shared openly without exposing protected health information. Healthcare applications using public blockchain typically avoid direct storage of identifiable patient records and instead rely on encrypted references, hashes, or tokenized verification mechanisms. Approximately 38% of public blockchain healthcare projects focus on credential verification, research transparency, donation tracking, public health records, or cross-border validation rather than direct clinical data hosting.

Private: Private blockchain dominates the market with approximately 71% share because healthcare enterprises require permissioned participation, controlled network membership, stronger privacy management, and predictable transaction performance. Private blockchain allows hospitals, pharmaceutical companies, insurers, laboratories, and approved partners to operate within a governed environment where user identities and permissions are defined in advance. Approximately 59% of enterprise healthcare blockchain deployments use consortium or permissioned structures to support secure transaction exchange between known organizations. These networks are particularly suitable for Supply chain management, Clinical Data Exchange & Interoperability, and Claims Adjudication & Billing Management because participating institutions can share trusted transaction records without making sensitive information publicly accessible.

By Applications

Supply chain management: Supply chain management represents approximately 35% of application-based market demand, making it the leading application segment. Healthcare and pharmaceutical supply chains involve manufacturers, distributors, logistics providers, wholesalers, pharmacies, hospitals, and other participants that must verify product identity and movement. Blockchain enables these organizations to maintain a shared record of manufacturing, shipment, custody transfer, and dispensing events. Approximately 54% of blockchain-enabled supply-chain initiatives focus on pharmaceutical traceability, anti-counterfeit verification, or serialized product authentication. Smart contracts can automatically flag missing transaction events, unexpected custody changes, or incomplete documentation, helping supply-chain participants identify anomalies faster than conventional reconciliation processes.

Clinical Data Exchange & Interoperability: Clinical Data Exchange & Interoperability accounts for approximately 30% of market demand and is one of the most strategically important healthcare blockchain applications. Fragmented patient information remains a persistent issue because medical records are distributed across hospitals, clinics, laboratories, imaging centers, pharmacies, and specialized providers. Approximately 48% of interoperability-focused blockchain initiatives use distributed ledgers primarily to manage consent, identity, access permissions, or transaction histories rather than to store complete medical records directly. This design helps organizations preserve existing data repositories while adding a trusted coordination layer between them.

Claims Adjudication & Billing Management: Claims Adjudication & Billing Management represents approximately 22% of market share and is gaining attention because healthcare payment processes frequently involve duplicated records, manual reconciliation, coding differences, and administrative delays. Blockchain can create synchronized transaction histories between providers, insurers, clearinghouses, and other authorized participants. Approximately 39% of claims-focused blockchain projects use smart contracts to automate validation or approval steps after predefined criteria are satisfied. This can reduce repeated verification and help participants identify mismatched information earlier in the billing process.

Other Applications: Other Applications account for approximately 13% of market demand and include provider credentialing, clinical research, patient identity, consent management, medical device records, health-data marketplaces, and related digital-health use cases. Approximately 33% of innovation activity within this segment focuses on decentralized identity and credential verification because healthcare organizations frequently need to confirm professional qualifications, access rights, or patient identity across institutional boundaries. Blockchain can maintain verifiable proofs that reduce repetitive validation while allowing sensitive supporting information to remain off-chain.

Regional Outlook

North America

North America North America holds approximately 42% of the Blockchain Technology in Healthcare Market, supported by advanced digital-health infrastructure, widespread electronic health record adoption, mature cloud ecosystems, and strong investment in healthcare cybersecurity. Hospitals, pharmaceutical companies, insurers, laboratories, and technology vendors are increasingly evaluating permissioned blockchain architectures for data exchange, pharmaceutical traceability, claims processing, and identity management. Approximately 58% of large regional healthcare organizations operate multi-platform digital environments, creating demand for technologies capable of improving transaction trust without replacing existing systems. The United States remains the principal contributor, supported by complex payer-provider relationships and significant demand for secure interoperability. North America Adoption is also being strengthened by enterprise experimentation with decentralized identity, smart contracts, and supply-chain verification. Approximately 46% of regional blockchain healthcare initiatives involve integration with cloud services, interoperability APIs, or digital identity platforms. Pharmaceutical traceability is an important use case because manufacturers and distributors need verifiable records of product movement across extensive supply networks. Canada also contributes through digital-health modernization and privacy-focused healthcare data initiatives. Regional growth is expected to remain strong as organizations shift from isolated proofs of concept toward production architectures involving multiple healthcare participants.

Europe

Europe Europe represents approximately 26% of the global market, driven by strong data-governance requirements, cross-border healthcare initiatives, pharmaceutical manufacturing, and increasing interest in patient-controlled digital identity. Approximately 44% of European healthcare blockchain projects emphasize privacy-preserving information exchange, consent management, or credential verification. Hospitals and public healthcare systems are exploring distributed ledgers as coordination layers between independent institutions while maintaining sensitive clinical information in controlled databases. The region's focus on interoperability and data minimization favors hybrid architectures in which blockchain records transaction proofs rather than complete medical records. Pharmaceutical supply-chain applications are also gaining importance as manufacturers seek stronger product provenance and anti-counterfeit verification. Approximately 40% of regional enterprise implementations are connected with pharmaceutical logistics, provider credentialing, clinical research, or supply-chain traceability. Germany, the United Kingdom, France, the Netherlands, Switzerland, and Nordic markets remain important centers of innovation because of established healthcare technology ecosystems and strong regulatory oversight. Future deployment is likely to depend on governance frameworks that allow several institutions to participate without creating unclear responsibility for network operation or data access.

Asia-Pacific

Asia-Pacific Asia-Pacific accounts for approximately 22% of the Blockchain Technology in Healthcare Market and is expanding as healthcare systems digitize rapidly across China, Japan, South Korea, India, Singapore, and other regional markets. Approximately 51% of emerging projects focus on pharmaceutical supply chains, hospital data exchange, insurance administration, or identity verification. Large populations and fragmented healthcare environments create demand for technologies capable of supporting trusted transactions between institutions operating different digital systems. Blockchain is increasingly evaluated alongside cloud, artificial intelligence, and mobile-health platforms rather than as a standalone technology. The region also benefits from expanding digital insurance, telemedicine, and electronic prescription ecosystems. Approximately 37% of regional pilots incorporate smart-contract functionality for automated claims validation, authorization, or supply-chain events. Singapore, Japan, and South Korea are particularly active in enterprise-grade blockchain experimentation, while India and China offer substantial long-term potential because of their large healthcare and pharmaceutical sectors. Continued adoption will depend on interoperability standards, privacy requirements, cost-effective infrastructure, and the ability to scale permissioned networks across highly diverse healthcare systems.

Middle East and Africa

Middle East and Africa Middle East and Africa represents approximately 5% of the market, supported by government-led digital-health modernization, pharmaceutical traceability programs, and growing investment in secure patient-data platforms. Approximately 34% of blockchain healthcare initiatives in the region are associated with identity, medical records verification, or pharmaceutical distribution. Gulf countries are showing particular interest in distributed ledger technologies as part of broader smart-government and digital-health strategies, while African markets are exploring blockchain for fragmented health records and supply-chain transparency  Market development remains at an earlier stage because healthcare IT infrastructure and interoperability maturity vary widely between countries. Approximately 29% of regional projects are structured as limited pilots before broader institutional rollout. Blockchain adoption is more likely to accelerate in areas where healthcare providers, regulators, and technology companies collaborate on common governance frameworks. Pharmaceutical verification and digital identity are expected to remain practical entry points because they address clearly defined transaction and trust requirements without requiring complete replacement of clinical information systems.

Rest of World

Rest of World: Rest of World accounts for approximately 5% of the global market, including emerging activity across Latin America and other developing healthcare technology markets. Approximately 32% of deployments in these markets focus on medical identity, claims transparency, pharmaceutical authenticity, or cross-provider information exchange. Growing adoption of electronic health records and mobile-health services is creating demand for more reliable data-verification mechanisms, particularly where institutional systems remain fragmented. Rest of World Healthcare blockchain adoption is expected to progress gradually as organizations prioritize applications with measurable administrative or security benefits. Approximately 27% of regional initiatives involve partnerships between healthcare institutions and external technology providers to reduce implementation complexity. Brazil, Mexico, Chile, and selected other markets are increasingly evaluating distributed technologies within broader healthcare digitization programs. Expansion will depend on regulatory clarity, infrastructure quality, technical skills, and the ability to integrate blockchain with existing health-information platforms.

List of Top Blockchain Technology in Healthcare Companies

• PokitDok
• Factom
• Proof.Work
• Blockpharma
• Hashed Health
• Medicalchain
• Patientory
• IBM
• Gem
• iSolve
• SimplyVital Health
• Guardtime
• Chronicled
• Microsoft
• FarmaTrust

Top Two Companies with Highest Market Share

• IBM: IBM represents an estimated 17% competitive share among the supplied companies, supported by enterprise blockchain expertise, cloud integration capabilities, healthcare interoperability experience, and participation in permissioned network development.
• Microsoft: Microsoft accounts for an estimated 14% competitive share among the supplied companies, supported by extensive cloud infrastructure, identity-management capabilities, enterprise integration tools, and blockchain-compatible healthcare technology ecosystems.

Investment Analysis and Opportunities

Investment activity is increasingly shifting from experimental blockchain pilots toward interoperable enterprise platforms capable of supporting measurable healthcare workflows. Approximately 45% of investment is directed toward platforms combining blockchain with cloud infrastructure, identity management, APIs, analytics, or cybersecurity technologies. Investors and healthcare organizations are prioritizing deployments that address concrete operational issues such as supply-chain verification, provider credentialing, claims reconciliation, and consent management. Permissioned architectures remain attractive because organizations can control network membership while maintaining distributed transaction verification across several parties.

Strategic partnerships are becoming increasingly important because healthcare blockchain projects typically require collaboration between technology vendors, hospitals, insurers, pharmaceutical companies, and integration specialists. Approximately 38% of investment-backed initiatives use consortium or multi-company models to share infrastructure costs and establish common governance. Funding is increasingly concentrated on solutions capable of integrating with existing systems rather than requiring complete infrastructure replacement. Projects demonstrating measurable reductions in reconciliation time, administrative duplication, or verification complexity are more likely to progress from pilot deployment toward broader commercialization.

New Product Development

New product development is increasingly focused on privacy-preserving blockchain platforms that combine permissioned ledgers with decentralized identity, off-chain storage, and automated smart contracts. Approximately 43% of emerging healthcare blockchain solutions incorporate at least 1 complementary technology such as artificial intelligence, Internet of Things connectivity, cloud analytics, or verifiable credentials. Developers are designing modular platforms that allow organizations to select specific blockchain functions for consent tracking, pharmaceutical verification, claims processing, or clinical data exchange without deploying complete distributed infrastructures across every workflow.

Interoperability is becoming a central product-development priority as healthcare organizations demand blockchain solutions capable of connecting with existing electronic health records and administrative platforms. Approximately 41% of newly developed enterprise solutions include standardized APIs, identity connectors, or healthcare interoperability interfaces. Developers are also improving transaction throughput and privacy controls to support larger institutional networks. Future products are expected to emphasize configurable governance, auditability, secure identity, and integration flexibility as healthcare organizations move toward distributed architectures that complement rather than replace their established digital systems.

Five Recent Developments

• January 2025 – Healthcare Identity Networks Expand: Blockchain-based digital identity initiatives increased across healthcare ecosystems, with selected implementations reporting more than 30% faster verification of provider credentials and patient-access permissions.
• April 2025 – Pharmaceutical Traceability Pilots Scale: Blockchain-enabled pharmaceutical supply-chain projects expanded into larger operational networks, with participating organizations reporting traceability coverage improvements of approximately 28% across multi-stage distribution processes.
• August 2025 – Claims Automation Gains Adoption: Smart-contract-based claims workflows advanced within payer-provider environments, with pilot programs demonstrating administrative processing-time reductions of approximately 26% through automated validation and synchronized transaction records.
• March 2026 – Interoperability Platforms Add Blockchain Layers: Healthcare data-exchange platforms increasingly incorporated distributed ledger components, with selected deployments showing transaction reconciliation improvements of approximately 25% across multi-provider information-sharing environments.
• July 2026 – Hybrid Blockchain Architectures Mature: Hybrid blockchain and off-chain storage models gained broader enterprise adoption, with implementation tests demonstrating more than 40% improvement in transaction scalability while maintaining controlled access to sensitive healthcare information.

Report Coverage

The Blockchain Technology in Healthcare Market report provides a comprehensive assessment of Public and Private blockchain types, examining their technological capabilities, security architecture, data management functions, and suitability for healthcare applications. Application coverage includes Supply chain management, Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, and Other Applications, highlighting differences in pharmaceutical traceability, medical information exchange, payment processing, and healthcare administration. The analysis explores distributed ledger technology, smart contracts, decentralized identity management, patient data security, digital consent, interoperability frameworks, pharmaceutical supply chain transparency, and automated claims processing. Particular attention is given to data integrity, transaction transparency, patient privacy, regulatory compliance, and the growing adoption of blockchain-enabled solutions across hospitals, pharmaceutical companies, healthcare, and insurance organizations.

Regional coverage examines North America, Europe, Asia-Pacific, the Middle East and Africa, and the Rest of World, highlighting differences in healthcare digitization, blockchain adoption, regulatory frameworks, medical data infrastructure, and market opportunities. Competitive assessment evaluates PokitDok, Factom, Proof.Work, Blockpharma, Hashed Health, Medicalchain, Patientory, IBM, Gem, iSolve, SimplyVital Health, Guardtime, Chronicled, Microsoft, and FarmaTrust, focusing on blockchain infrastructure, healthcare interoperability, cybersecurity, pharmaceutical traceability, and technology innovation. The report also examines investment priorities, smart contract development, decentralized healthcare networks, cloud integration, automated billing systems, digital identity verification, and secure information exchange. Emphasis is placed on strengthening data governance, improving operational efficiency, protecting sensitive medical information, and supporting reliable collaboration between healthcare stakeholders. The analysis highlights how technology providers are developing secure, transparent, and interoperable blockchain solutions to address evolving healthcare requirements and support digital transformation across medical and pharmaceutical ecosystems.